FDA Guidance May Move Goalposts For Form 483 Responses
The U.S. Food and Drug Administration has issued new draft guidance giving drug manufacturers — for the first time — formal guidance on how the agency expects firms to respond to...To view the full article, register now.
Already a subscriber? Click here to view full article